We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Overcoming the Identification Bottleneck in Untargeted Metabolomics: Combining Technological and Software Innovations

Article   Jan 25, 2019 | By Warwick Dunn, Professor of Analytical and Clinical Metabolomics, School of Bioscience, University of Birmingham.

 
Overcoming the Identification Bottleneck in Untargeted Metabolomics: Combining Technological and Software Innovations

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

A Leading Voice for T-Cell Expertise During COVID-19 and Beyond

Article

The unprecedented scale of global scientific collaboration, including the establishment of expert consortia, has played an important part in addressing the COVID-19 pandemic. We spoke to Professor Danny Altmann, chair of the Global T cell Expert Consortium (GTEC) about the role that T cells have in viral infections like SARS-CoV-2 and what GTEC is hoping to achieve.

READ MORE

Stay Up-to-Date With COVID-19 Drug Development

Article

Researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

READ MORE

One Step Closer to CRISPR-Cas9 Cancer Therapies

Article

Although not fully deterministic for the development of cancer, certain genes – such as the BRCA1 gene, are well known to be implicated and to significantly raise a person’s cancer risk. Why is it then, that we have not heard more about CRISPR-Cas9 being developed for cancer therapies?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Informatics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE